Following the Technology Appraisal Committee meeting on 24 May 2023, we are consulting with consultees and commentators on the case for extending the statutory 3-month period for funding of hybrid closed loop systems for managing blood glucose levels in type 1 diabetes. Once this consultation has ended, we will issue the Final Appraisal Document (FAD) for appeal and anticipate publishing final guidance on this appraisal in December 2023.
The request to vary the funding requirement timeframe for implementation received from NHS England has been added to the website for information.
This page was last updated: